Products for Research Use Only
RegisterLogin

Frovocimab

CAT: 0804-HY-P99626-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99626-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9. Frovocimab inhibits PCSK9 binding to LDL receptor (LDLR) while permitting the normal proteolytic cleavage of the bound intact PCSK9[1].
CAS Number
1643672-70-1
Product Name Alternative
LY 3015014
UNSPSC
12352203
Target
PCSK9
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/frovocimab.html
Purity
99.87
Solubility
10 mM in DMSO
Smiles
[Frovocimab]
Molecular Weight
(146.38 kDa)
References & Citations
[1]Krista M Schroeder, et al. Proteolytic cleavage of antigen extends the durability of an anti-PCSK9 monoclonal antibody. J Lipid Res. 2015 Nov;56 (11) :2124-32.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
abx831487-01Frovocimab
GTR18337754-01Frovocimab Antibody
591875Frovocimab (PCSK9)
HV275036-01Research Grade Frovocimab
KPTX268Frovocimab ELISA Kit
C00627-1mg*25Frovocimab (Anti-PCSK9)
048151PCSK9 (frovocimab) discontinued
E55B0539Frovocimab (Reference antibody)

Popular Products